1. Conen A, Raabe A, Schaller K, Fux CA, Vajkoczy P, Trampuz A. Management of neurosurgical implant-associated infections. Swiss Med Wkly. 2020 Apr 24;150:w20208.
2. Dawod J, Tager A, Darouiche RO, Al Mohajer M. Prevention and management of internal cerebrospinal fluid shunt infections. J Hosp Infect. 2016 Aug;93(4):323-8.
3. Bhimraj A, Tunkel AR. Cerebrospinal Fluid Shunt and Drain Infections. In: Bennet JE, Doin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases,
9th edition. Philadelphia, PA 19103-2899: Elseiver; 2020.
4. Tunkel AR, Hasbun R, Bhimraj A, et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017
Mar 15;64(6):e34-e65.
5. Langley JM, Gravel D, Moore D, et al. Study of cerebrospinal fluid shunt-associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Prog-
ram. Infect Control Hosp Epidemiol. 2009;30:285–288.
6. Kanangi SMR, Balasubramaniam C. Shunt infections: a review and analysis of a personal series. Childs Nerv Syst. 2018 Oct;34(10):1915-1924.
7. Choux M, Genitori L, Lang D, et al. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg. 1992;77:875–880.
8. Winston KR. Hair and neurosurgery. Neurosurgery. 1992;31:320–329.
9. Morissette I, Gourdeau M, Francoeur J. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci. 1993;20:118–122.
10. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2008 Feb;62 Suppl 2:688-700.
11. Dorresteijn KRIS, Jellema K, van de Beek D, Brouwer MC. Factors and measures predicting external CSF drain-associated ventriculitis: A review and meta-analysis. Neurology. 2019 Nov
26;93(22):964-972.
12. Ramanan M, Lipman J, Shorr A, Shankar A. A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis. 2015 Jan 8;15:3.
13. Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg HM, Jane JA, Ward JD, Young HF, Marmarou A: Ventriculostomy infections: The effect of monitoring duration and catheter
exchange in 584 patients. J Neurosurg 85:419–424, 1996.
14. Kim DK, Uttley D, Bell BA, Marsh HT, Moore AJ: Comparison of rates of infection of two methods of emergency ventricular drainage. J Neurol Neurosurg Psychiatry 58:444–446, 1995.
15. Lyke KE, Obasanjo OO, Williams MA, O’Brien M, Chotani R, Perl TM: Ventriculitis complicating use of intraventricular catheters in adult neuro- surgical patients. Clin Infect Dis 33:2028–
2033, 2001.
16. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, Narayan RK: Ventriculostomy-related infections: A prospective epidemio- logic study. N Engl J Med 310:553–559,
1984.
17. OhrstromJK, SkouJK,EjlertsenT,KosteljanetzM:Infectedventriculostomy: Bacteriology and treatment. Acta Neurochir (Wien) 100:67–69, 1989.
18. Paramore CG, Turner DA: Relative risks of ventriculostomy infection and morbidity. Acta Neurochir (Wien) 127:79–84, 1994.
19. Schultz M, Moore K, Foote AW: Bacterial ventriculitis and duration of ventriculostomy catheter insertion. J Neurosci Nurs 25:158–164, 1993.
20. Stenager E, Gerner-Smidt P, Kock-Jensen C: Ventriculostomy-related infections: An epidemiological study. Acta Neurochir (Wien) 83:20–23, 1986.
21. Poon WS, Ng S, Wai S: CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: A randomised study. Acta Neurochir Suppl 71:146– 148, 1998.
22. Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr 2014; 13:301–6.
23. Ghosh D, Mainali G, Khera J, Luciano M. Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg 2013; 49:138–44.
24. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001;94:195–201.
25. Jamjoom AAB, Joannides AJ, Poon MT, et al. Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland. J Neurol Neurosurg Psychiatry. 2018
Feb;89(2):120-126.
26. Montero A, Romero J, Vargas JA, et al. Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir (Wien). 2000;142(1):67-74.
27. Conen A, Walti LN, Merlo A, et al. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin
Infect Dis. 2008;47:73–82.
28. Chung JJ, Yu JS, Kim JH, et al. Intraabdominal complications secondary to ventriculoperitoneal shunts: CT findings and review of the literature. AJR Am JRoentgenol. 2009;193:1311–1317.
29. Forward KR, Fewer HD, Stiver HG. Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients. J Neurosurg. 1983 Sep;59(3):389-94. doi: 10.3171/jns.1983.59.3.0389.
30. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. (January, 2024) Available at: https://www.cdc.gov/nhsn/pdfs/pscmanu-
al/17pscnosinfdef_current.pdf (Accessed on June 2024).
31. Banks JT, Sharara S, Tubbs RS, et al. Polymerase chain reaction for the rapid detection of cerebrospinal fluid shunt or ventriculostomy infections. Neurosurgery.2005;57:1237–1243.
32. Deutch S, Dahlberg D, Hedegaard J, Schmidt MB, Moller JK, Ostergaard L. Diagnosis of ventricular drainage-related bacterial meningitis by broad-range real-time polymerase chain reaction.
Neurosurgery 2007; 61:306–11; discussion 11–2.
33. Li Y, Zhang G, Ma R, et al. The diagnostic value of cerebrospinal fluids procalcitonin and lactate for the differential diagnosis of post-neurosurgical bacterial meningitis and aseptic meningitis.
Clin Biochem. 2015 Jan;48(1-2):50-4.
34. Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg. 2001
Oct;35(4):205-10.
35. EE) James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery. 1980 Nov;7(5):459-63.
36. FF) Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J. 2002 Jul;21(7):632-6.
37. Brown EM, Edwards RJ, Pople IK. Conservative management of patients with cer- ebrospinal fluid shunt infections. Neurosurgery 2006; 58:657–65.
38. Pelegrín I, Lora-Tamayo J, Gómez-Junyent J, Sabé N, García-Somoza D, Gabarrós A, et al. Management of ventriculoperitoneal shunt infections in adults: Analysis of risk factors associated
with treatment failure. Clin Infect Dis. 2017;64(8):989–97.
39. Stenehjem E, Armstrong WS. Central nervous system device infections. Infect Dis Clin North Am 2012; 26:89–110.
40. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007; 41:296.
41. Myrianthefs P, Markantonis SL, Vlachos K, et al. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006; 50:3971.
42. Robinson JL, Freire D, Bialy L. Treatment strategies for cerebrospinal shunt infections: a systematic review of observational studies. BMJ Open 2020;10:e038978.
43. Kestle JR, Garton HJ, Whitehead WE, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg 2006; 105:177–81.